Key result
This review provides structural insights and chemical space parameters of small molecules targeting the renin-angiotensin-aldosterone system to guide rational drug discovery for cardiovascular diseases.
Why the study?
Disruption of RAAS homeostasis often leads to cardiovascular diseases, necessitating a comprehensive understanding of RAAS signaling mechanisms, current small-molecule modulators, and their structural insights to guide rational drug discovery.
This review provides structural and functional insights into RAAS modulators to assist medicinal chemists in developing new therapeutics with improved selectivity and efficacy for cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
May guide RAAS modulator discovery; leaves open clinical translation pending prospective trials.
Renin-angiotensin-aldosterone system (RAAS) is crucial in cardiovascular homeostasis. Any disruption in this homeostasis often leads to numerous cardiovascular diseases (CVDs) and non-cardiovascular diseases. Small molecules that show ability toward mechanically modulating RAAS components have been developed to address this problem, thus providing opportunities for innovative drug discovery and development. This review is put forth to provide a comprehensive understanding not only on the signaling mechanisms of RAAS that lead to cardiovascular events but also on the use of small molecules targeting the modulation of RAAS components. Further, the detailed descriptions of the drugs affecting the RAAS and their pharmacodynamics, kinetics, and metabolism profiles are provided. This article also covers the limitations of the present therapeutic armory, followed by their mechanistic insights. A brief discussion is offered on the analysis of the chemical space parameters of the drugs affecting RAAS compared to other cardiovascular and renal categories of medications approved by the US FDA. This review provides structural insights and emphasizes the importance of integrating the current therapeutic regimen with pharmacological tactics to accelerate the development of new therapeutics targeting the RAAS components for improved and efficacious cardiovascular outcomes. Finally, chemical spacing parameters of RAAS modulators are provided, which will help in understanding their peculiarities in modulating the RAAS signaling through structural and functional analyses. Furthermore, this review will assist medicinal chemists working in this field in developing better drug regimens with improved selectivity and efficacy.
No takes yet. Share an insight, caveat, or question.
Bansal et al. (2025) conducted a review in Cardiovascular diseases. Small molecules targeting the renin-angiotensin-aldosterone system (RAAS) was evaluated. This review provides structural insights and chemical space parameters of small molecules targeting the renin-angiotensin-aldosterone system to guide rational drug discovery for cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: